Emerging therapies for the prevention and treatment of oral mucositis. - Wikidata - awgldk - TriplyDB

Emerging therapies for the prevention and treatment of oral mucositis.

Emerging therapies for the prevention and treatment of oral mucositis.

http://www.wikidata.org/entity/Q34432808

about

Radioprotectors and Radiomitigators for Improving Radiation Therapy: The Small Business Innovation Research (SBIR) Gateway for Accelerating Clinical Translation.Oral Mucositis: Melatonin Gel an Effective New Treatment.New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury Healing acceleration of oral mucositis induced by 5-fluorouracil with Pistacia atlantica (bene) essential oil in hamsters.Oral health-related concerns, behavior, and communication with health care providers of patients with breast cancer: impact of different treatments.Milk diets influence doxorubicin-induced intestinal toxicity in piglets.A Review of Clinical Radioprotection and Chemoprotection for Oral Mucositis.

P2860

Q24282585-7825D70B-1C21-4EB1-A6A0-831B6BDFF176 Q33755115-227D202D-7757-4F76-8510-87BC0C3CC4D2 Q33774917-0BC69A64-B3BA-4B2C-8104-00E09F3704E5 Q46714687-D4D87074-B28D-47A2-A7AD-13386835CA2E Q50030410-90039C88-9509-4140-8F5A-E3345501C1F9 Q51625141-352B24EB-BB9F-4C23-A1BB-CB942CB13399 Q52560942-819625E2-07F9-4A93-9FB6-186CBA61415C

P2860

Emerging therapies for the prevention and treatment of oral mucositis.

http://www.wikidata.org/entity/Q34432808

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Emerging therapies for the prevention and treatment of oral mucositis.

@ast

Emerging therapies for the prevention and treatment of oral mucositis.

@en

Emerging therapies for the prevention and treatment of oral mucositis.

@nl

type

label

Emerging therapies for the prevention and treatment of oral mucositis.

@ast

Emerging therapies for the prevention and treatment of oral mucositis.

@en

Emerging therapies for the prevention and treatment of oral mucositis.

@nl

prefLabel

Emerging therapies for the prevention and treatment of oral mucositis.

@ast

Emerging therapies for the prevention and treatment of oral mucositis.

@en

Emerging therapies for the prevention and treatment of oral mucositis.

@nl

P1433

Q34432808-E53BDB58-BF14-4CEE-9202-0D6C7945A40B

P1476

Q34432808-26C4E67C-DC61-493D-AFB5-3A3B9233D20C

P2093

Q34432808-3963F195-202E-42D0-90B2-2A330DCE754D

P2860

Q34432808-13ED1582-DA93-4ABD-8C4C-AB17A8A4CCA8

Q34432808-143BAFB9-1352-430A-B514-029B9086C096

Q34432808-28D1C526-DDE5-4F33-B28D-4C5D17EBAC70

Q34432808-44F5F0FB-4F2D-42B5-8AC9-8066CD97CA9A

Q34432808-49769F71-435B-40D2-8A93-7437667DA54A

Q34432808-534C36AE-2938-4FC1-AD74-835FB6680D5E

Q34432808-57D6820C-890C-492E-9DFA-974C3171A62A

Q34432808-59B0ECB2-3ABC-4F14-8FA6-F1FAA27C3863

Q34432808-5D520FB7-42D1-44F8-AE54-99536669352D

Q34432808-68D42755-1FE2-46CF-B99D-E82A754A48BA

P304

Q34432808-DF683DFB-2362-4FE6-9401-3B4FD812CDF3

P31

Q34432808-C4B2BF03-82EE-4128-8F5A-6C30A770CF4F

P356

Q34432808-FDCA5545-992D-40B1-BA8B-F9329EAD1F74

P407

Q34432808-AA339677-E46E-4743-81C9-DDAC5E620762

P433

Q34432808-1103DA2C-A95B-4F2E-A857-F8E72E17C8A5

P478

Q34432808-40FEAB4B-D281-4F65-8005-1283D63CE3A4

P50

Q34432808-55A7CEA5-9D9F-4E3A-9650-499A175FDA86

P577

Q34432808-37DCB305-475D-41F5-A03F-4FCFC55E8640

P5875

Q34432808-940801A9-0B5A-4898-AF0F-54CE04EA9F7C

P698

Q34432808-FFC8A074-6547-48BA-9801-EB4A36992CFB

P356

14728214.2014.946403

P1433

Expert Opinion on Emerging Drugs

P1476

Emerging therapies for the prevention and treatment of oral mucositis

@en

P2093

Stephen Sonis

http://www.w3.org/2001/XMLSchema#string

P2860

Palifermin for oral mucositis after intensive therapy for hematologic cancers

Efficacy of a supersaturated calcium phosphate oral rinse for the prevention and treatment of oral mucositis in patients receiving high-dose cancer therapy: a review of current data.

Patient preferences regarding side effects of chemotherapy for ovarian cancer: do they change over time?

Multi-institutional, randomized, double-blind, placebo-controlled trial to assess the efficacy of a mucoadhesive hydrogel (MuGard) in mitigating oral mucositis symptoms in patients being treated with chemoradiation therapy for cancers of the head an

The impact of concurrent granulocyte-macrophage colony-stimulating factor on quality of life in head and neck cancer patients: results of the randomized, placebo-controlled Radiation Therapy Oncology Group 9901 trial.

Mucositis: The impact, biology and therapeutic opportunities of oral mucositis.

Systematic review of amifostine for the management of oral mucositis in cancer patients.

The economic burden of toxicities associated with cancer treatment: review of the literature and analysis of nausea and vomiting, diarrhoea, oral mucositis and fatigue.

Adverse event reporting in cancer clinical trial publications.

SNP-based Bayesian networks can predict oral mucositis risk in autologous stem cell transplant recipients.

P304

343-351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728214.2014.946403

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264563205

http://www.w3.org/2001/XMLSchema#string

P698

25102771

http://www.w3.org/2001/XMLSchema#string